Thymalin (20mg)

Thymalin is a nonapeptide produced by two distinct epithelial populations in the thymus first described by Bach in 1977. The hormone is believed to be involved in T-cell differentiation and enhancement of T and NK cell actions. Besides this rather paracrine or auto-organic effects on the thymus dependent immune system, thymalin seems to have neuroendocrine effects as well.

A recent focus has been on the role of thymulin as an effector on proinflammatory mediators/cytokines. A peptide analog of thymulin (PAT) has been found to have analgesic effects in higher concentrations and particularly neuroprotective anti-inflammatory effects in the CNS. Astrocytes seem to be the target for thymulin for this effect. Researchers hope to develop drugs thwarting inflammatory processes associated with neurodegenerative diseases and even rheumatism with the help of thymulin analogs.

Comparative studies were performed examining the effects thymalin and the short peptide complexes had on immunogenesis by taking spleen tissue cultures of both young and old mice. Following administration of the short peptides EW, KE, and EDP there were notable changes in both apoptosis levels and proliferation rate. Overall the short peptide complexes led to an increase in cell proliferation, a 20-50% increase in the growth index, and a 29-42% reduction in apoptosis. Thymalin supplementation led to even more drastic results potentially due to the presence of all three of the short peptides.  

The primary concern for peptide researchers today is product purity.  Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.

THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION.

ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.